Opus Point Partners Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$261K Hold
1,123
0.47% 46
2019
Q2
$263K Buy
+1,123
New +$259K 0.39% 56
2019
Q1
Sell
-1,062
Closed -$320K 76
2018
Q4
$320K Buy
1,062
+30
+3% +$9.57K 0.7% 23
2018
Q3
$365K Sell
1,032
-2,500
-71% -$861K 0.87% 38
2018
Q2
$1.02M Buy
3,532
+15
+0.4% +$4.22K 2.22% 18
2018
Q1
$963K Sell
3,517
-2,276
-39% -$706K 1.89% 17
2017
Q4
$1.84M Sell
5,793
-894
-13% -$287K 1.6% 21
2017
Q3
$2.09M Buy
6,687
+910
+16% +$269K 1.88% 24
2017
Q2
$1.57M Sell
5,777
-5,627
-49% -$1.49M 1.44% 28
2017
Q1
$3.12M Buy
11,404
+532
+5% +$150K 2.31% 22
2016
Q4
$3.08M Buy
10,872
+168
+2% +$49.8K 2.46% 16
2016
Q3
$3.35M Buy
10,704
+1,662
+18% +$492K 1.88% 12
2016
Q2
$2.19M Sell
9,042
-2,083
-19% -$549K 2.11% 22
2016
Q1
$2.9M Buy
11,125
+643
+6% +$170K 2.24% 21
2015
Q4
$3.21M Sell
10,482
-6,985
-40% -$2.01M 2.12% 21
2015
Q3
$5.1M Buy
17,467
+6,213
+55% +$2.05M 2.81% 7
2015
Q2
$4.55M Buy
11,254
+1,923
+21% +$772K 3.6% 9
2015
Q1
$3.94M Sell
9,331
-155
-2% -$61.1K 3.3% 8
2014
Q4
$3.22M Buy
+9,486
New +$3.07M 3.19% 12

Other funds holding BIIB

Opus Point Partners Management's BIIB Position: Q3 2019 in Review

Opus Point Partners Management held its Biogen (BIIB) position steady in Q3 2019 at 1,123 shares worth $261K. The position accounts for 0.47% of the portfolio, ranked #46.

Opus Point Partners Management first reported a position in BIIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $5.1M in Q3 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Opus Point Partners Management held 1,123 shares of Biogen worth $261K as of Q3 2019.
  • Opus Point Partners Management left its Biogen share count unchanged in Q3 2019.
  • Biogen made up 0.47% of Opus Point Partners Management's portfolio in Q3 2019, its #46 holding.
  • Opus Point Partners Management first reported a position in Biogen in Q4 2014 and has held it in 19 quarters since.
  • Opus Point Partners Management's Biogen position peaked at $5.1M in Q3 2015.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.